Q1 EPS Forecast for Acadia Healthcare Reduced by Analyst

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at Leerink Partnrs dropped their Q1 2025 earnings per share estimates for Acadia Healthcare in a research note issued on Thursday, December 12th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of $0.72 for the quarter, down from their previous forecast of $0.76. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare’s Q2 2025 earnings at $0.87 EPS, Q3 2025 earnings at $0.87 EPS, Q4 2025 earnings at $0.80 EPS, FY2025 earnings at $3.26 EPS and FY2026 earnings at $3.95 EPS.

A number of other analysts also recently commented on ACHC. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Barclays cut their price target on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their target price for the company from $45.00 to $75.00 in a report on Thursday. Finally, KeyCorp started coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $40.66 on Monday. The stock has a market capitalization of $3.78 billion, a price-to-earnings ratio of 13.33, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The firm has a 50-day simple moving average of $45.39 and a 200-day simple moving average of $61.79. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the company earned $0.91 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year.

Institutional Trading of Acadia Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. GAMMA Investing LLC boosted its stake in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after buying an additional 241 shares during the period. Blue Trust Inc. lifted its holdings in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after acquiring an additional 248 shares during the last quarter. Commonwealth Equity Services LLC boosted its position in shares of Acadia Healthcare by 3.5% during the 2nd quarter. Commonwealth Equity Services LLC now owns 7,595 shares of the company’s stock worth $513,000 after purchasing an additional 257 shares during the period. Atria Investments Inc increased its holdings in Acadia Healthcare by 4.7% in the 3rd quarter. Atria Investments Inc now owns 6,844 shares of the company’s stock valued at $434,000 after purchasing an additional 308 shares during the last quarter. Finally, KBC Group NV lifted its stake in Acadia Healthcare by 14.4% during the third quarter. KBC Group NV now owns 2,688 shares of the company’s stock worth $170,000 after purchasing an additional 338 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.